Obinutuzumab vs Rituximab in FL: ' Too Close to Call ' Obinutuzumab vs Rituximab in FL: ' Too Close to Call '

Obinutuzumab for induction and maintenance provides significantly higher PFS than rituximab, the current standard of care for follicular lymphoma (FL). But an editorial cautions it ' s too soon to tell.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news